Active, not recruitingPhase 3NCT00310180
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Studying Hinman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Joseph A SparanoECOG-ACRIN Cancer Research Group
- Intervention
- Anastrozole(drug)
- Enrollment
- 10273 target
- Eligibility
- 18-75 years · FEMALE
- Timeline
- 2006 – 2030
Study locations (30)
- Northeast Alabama Regional Medical Center, Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Mobile Infirmary Medical Center, Mobile, Alabama, United States
- Providence Hospital, Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
- Alaska Regional Hospital, Anchorage, Alaska, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Fairbanks Memorial Hospital, Fairbanks, Alaska, United States
- Banner Thunderbird Medical Center, Glendale, Arizona, United States
- Banner Desert Medical Center, Mesa, Arizona, United States
- Banner Baywood Medical Center, Mesa, Arizona, United States
- Banner-University Medical Center Phoenix, Phoenix, Arizona, United States
- Western Regional CCOP, Phoenix, Arizona, United States
- Virginia G Piper Cancer Care-Del Camino, Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
American College of Surgeons · Cancer and Leukemia Group B · NSABP Foundation Inc · NCIC Clinical Trials Group · North Central Cancer Treatment Group · SWOG Cancer Research Network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00310180 on ClinicalTrials.govOther trials for Hinman syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07307274A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight AdultsSyntis Bio
- ACTIVE NOT RECRUITINGPHASE2NCT07281937A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesVerdiva Bio Dev Limited
- ENROLLING BY INVITATIONNANCT07283107Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean WomenNational University Hospital, Singapore
- RECRUITINGNANCT07268508Impact of a Pro-diversity Gut Microbiota Diet After a Bariatric Surgery on Gut Microbiota, Eating Behaviour and Sensory FunctionHospices Civils de Lyon
- RECRUITINGPHASE2NCT06927739Focused Orticumab Research for Treating Inflammation in Coronary ArteriesAbcentra
- RECRUITINGNANCT07054333Objective Measurement of Pain Regulation in Individuals Who Have Received Internet-delivered Exposure-based Cognitive Behavior TherapyKarolinska Institutet
- RECRUITINGPHASE4NCT07030517A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple MyelomaJohnson & Johnson Private Limited
- RECRUITINGPHASE2NCT06846320Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderAbbVie